Lei Huo

6.9k total citations · 1 hit paper
172 papers, 4.3k citations indexed

About

Lei Huo is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Lei Huo has authored 172 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 60 papers in Cancer Research and 40 papers in Molecular Biology. Recurrent topics in Lei Huo's work include Breast Cancer Treatment Studies (34 papers), Breast Lesions and Carcinomas (26 papers) and Cancer Genomics and Diagnostics (15 papers). Lei Huo is often cited by papers focused on Breast Cancer Treatment Studies (34 papers), Breast Lesions and Carcinomas (26 papers) and Cancer Genomics and Diagnostics (15 papers). Lei Huo collaborates with scholars based in United States, China and Hong Kong. Lei Huo's co-authors include Richard C. Scarpulla, Ayşegül A. Şahin, Kelly K. Hunt, Xiaoxian Li, Limin Peng, Kevin C. Ward, Ruth O’Regan, Erika Resetkova, Yun Gong and Jane Meisel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lei Huo

164 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis

2020 298 citations Lei Huo et al. profile →

Peers

Countries citing papers authored by Lei Huo

Since Specialization

Citations

This map shows the geographic impact of Lei Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Huo more than expected).

Fields of papers citing papers by Lei Huo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Huo. The network helps show where Lei Huo may publish in the future.

Co-authorship network of co-authors of Lei Huo

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Huo. A scholar is included among the top collaborators of Lei Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Huo. Lei Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation 2023 ·Archives of Pathology & Laboratory Medicine ·Jing Wang, (unknown), Hongxia Sun, Phyu P. Aung, Erika Resetkova, Clinton Yam, Ayşegül A. Şahin, Lei Huo, Qingqing Ding	9
2	Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma 2023 ·Cancers ·(unknown), Gene P. Siegal, (unknown), Ahmed Elkhanany, Lei Huo, Qingqing Ding, Ayşegül A. Şahin, Hua Guo, Cristina Magi‐Galluzzi, Shuko Harada, (unknown)	2
3	Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study 2023 ·Signal Transduction and Targeted Therapy ·Juxian Sun, (unknown), Chang Liu, Fan Zhang, (unknown), Wei‐Xing Guo, Lei Huo, Liping Zhou, Wan Yee Lau, Jie Shi, Shuqun Cheng	17
4	Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated? 2023 ·Clinical Breast Cancer ·Minhua Wang, Qingqing Ding, (unknown), (unknown), Lei Huo, Zhenya Tang, Hongxia Sun, (unknown), Guilin Tang, Bora Lim, Yun Wu, Constance T. Albarracin, Ayşegül A. Şahin, Hui Chen	2
5	The association of carbohydrate antigen 19‐9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study 2023 ·Cancer ·(unknown), Ping Yang, Xiaoliang Yang, Xianghua Zhang, (unknown), Xinyuan Lu, Lei Huo, (unknown), Xiangdong Wang, Huabang Zhou, Lu Wu, Ningyang Jia	1
6	Effect of Au film mask on antiwetting and antireflection properties of nanostructural polymer by plasma nanotexturing 2022 ·Surface Topography Metrology and Properties ·Xiaoyu Li, Yupeng Li, Lei Huo, M.K. Lei	0
7	MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 2022 ·Cancer Research ·Chengyue Wu, Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria, (unknown), Medine Böge, Lei Huo, Jason B. White, Debu Tripathy, Vicente Valero, Jennifer K. Litton, Clinton Yam, Jong Bum Son, Jingfei Ma, Gaiane M. Rauch, Thomas E. Yankeelov	45
8	SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression 2020 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Yizhou Wang, Renyan Gong, Jianbo Lin, Xifeng Li, (unknown), Lei Huo	13
9	A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer 2020 ·Investigational New Drugs ·Clinton Yam, Gaiane M. Rauch, (unknown), Meghan Karuturi, Elizabeth E. Ravenberg, Jason B. White, (unknown), (unknown), (unknown), Bora Lim, Jennifer K. Litton, (unknown), Sadia Saleem, James Stec, W. Fraser Symmans, Lei Huo, Senthil Damodaran, Ryan Sun, Stacy L. Moulder	24
10	Arterial hyperenhancement of small intrahepatic cholangiocarcinomas correlates with microvessel counts and patient survival 2019 ·HPB ·Xianghua Zhang, Lei Huo, Caifeng Liu, Feng Xu, Xinyuan Lu, Bin Huang, Ningyang Jia, Lu Wu, Feng Shen	1
11	Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions 2019 ·Annals of Surgical Oncology ·Tanya W. Moseley, Sejal Shah, (unknown), (unknown), Erika Resetkova, Nour Sneige, Kathy R. Brandt, Lei Huo	7
12	Maternal nutrition associated with nausea and vomiting during pregnancy: A prospective cohort China study 2017 ·Biomedical Research-tokyo ·Lei Huo, Bo Li, (unknown)	2
13	Emission of volatile organic compounds and production of secondary organic aerosol from stir-frying spices 2017 ·The Science of The Total Environment ·Tengyu Liu, Qianyun Liu, Zijun Li, Lei Huo, (unknown), Xue Li, Zhen Zhou, Chak K. Chan	55
14	Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer 2016 ·Breast Cancer Research and Treatment ·Xiaoxian Li, Jing Yang, Limin Peng, Ayşegül A. Şahin, Lei Huo, Kevin C. Ward, Ruth O’Regan, Mylin A. Torres, Jane Meisel	365
15	Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain 2014 ·Cancer Research ·Jinyu Chen, Ho-Jeong Lee, Xuefeng Wu, Lei Huo, Sun-Jin Kim, (unknown), Yan Wang, (unknown), Lakshmi Reddy Bollu, Guang Gao, Fei Su, James M. Briggs, Xiaojing Liu, Tamar Melman, John M. Asara, Isaiah J. Fidler, Lewis C. Cantley, Jason W. Locasale, Weihua Zhang	136
16	Absent, Small or Homeotic 2-like Protein (ASH2L) Enhances the Transcription of the Estrogen Receptor α Gene through GATA-binding Protein 3 (GATA3) 2014 ·Journal of Biological Chemistry ·Jin Qi, Lei Huo, Yiwei Tony Zhu, Yi-Jun Zhu, (unknown), (unknown)	17
17	Ultrasound‐guided fine‐needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas 2012 ·Cancer Cytopathology ·Lichao Zhao, Yun Gong, Jianping Wang, (unknown), Lei Huo, Nancy P. Caraway, Ming Guo	10
18	Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges 2011 ·Histopathology ·Feng Tang, Bing Wei, Zhen Tian, Michael Z. Gilcrease, Lei Huo, Constance T. Albarracin, Erika Resetkova, Hong Zhang, Ayşegül A. Şahin, Jieqing Chen, Hong Bu, Susan C. Abraham, Yun Wu	50
19	Is it too soon to start reporting HER2 genetic heterogeneity? 2010 ·Archives of Pathology & Laboratory Medicine ·Constance T. Albarracin, Mary E. Edgerton, Michael Z. Gilcrease, Lei Huo, Savitri Krishnamurthy, Lavinia P. Middleton, Erika Resetkova, Ayşegül A. Şahin, Nour Sneige, (unknown), Yun Wu	7
20	C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas 2005 ·Human Pathology ·Lei Huo, Jun Sugimura, Maria Tretiakova, Kurt T. Patton, Rohit Gupta, B. V. Popov, William B. Laskin, Anjana V. Yeldandi, Bin Tean Teh, Ximing J. Yang	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact